ConductScience.org, home

Paper37307481

Therapy targeting antigen-specific T cells by a peptide-based tolerizing vaccine against autoimmune arthritis.

Urbonaviciute V and 17 others. Proc Natl Acad Sci U S A, 2023. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Therapy targeting antigen-specific T cells by a peptide-based tolerizing vaccine against autoimmune arthritis. Papers, record 37307481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37307481

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapy targeting antigen-specific T cells by a peptide-based tolerizing vaccine against autoimmune arthritis.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.12
iCite
Revised in PubMed
2023-12-13
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Urbonaviciute VVilma
2Romero-Castillo LLaurahttps://orcid.org/0000-0002-0271-212X
3Xu BBingze
4Luo HHuqiaohttps://orcid.org/0000-0002-4249-0138
5Schneider NNadinehttps://orcid.org/0000-0002-0753-3710
6Weisse SSylviahttps://orcid.org/0000-0001-6438-7791
7Do NNNhu-Nguyenhttps://orcid.org/0000-0001-6483-8062
8Oliveira-Coelho AAnahttps://orcid.org/0000-0001-7783-9750
9Fernandez Lahore GGonzalohttps://orcid.org/0000-0002-4291-0251
10Li TTaotaohttps://orcid.org/0000-0001-6775-9976
11Sabatier PPierre
12Beusch CMChristian M
13Viljanen JJohan
14Zubarev RARoman Ahttps://orcid.org/0000-0001-9839-2089
15Kihlberg JJan
16Bäcklund JJohan
17Burkhardt HHaraldhttps://orcid.org/0000-0002-6261-3131
18Holmdahl RRikardhttps://orcid.org/0000-0002-4969-2576

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Autoimmune DiseasesMajor topic
Arthritis, RheumatoidMajor topic
Animals
Mice
Vaccines, Subunit
T-Lymphocytes, Regulatory
Antibodies

Source PubMed

Download CSV of topics

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123310951Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis.Arthritis Rheum2013https://conductscience.org/library/papers/23310951PubMed
211263770Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis.Arthritis Rheum2001https://conductscience.org/library/papers/11263770PubMed
335027402Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor.Ann Rheum Dis2022https://conductscience.org/library/papers/35027402PubMed
49510154Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.J Immunol1998https://conductscience.org/library/papers/9510154PubMed
526606968Type 1 diabetes immunotherapy using polyclonal regulatory T cells.Sci Transl Med2015https://conductscience.org/library/papers/26606968PubMed
612816990
Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
J Immunol2003https://conductscience.org/library/papers/12816990PubMed
78026530Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis.Eur J Immunol1994https://conductscience.org/library/papers/8026530PubMed
827009267Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis.Sci Transl Med2016https://conductscience.org/library/papers/27009267PubMed
916723470Treatment of autoimmune anterior uveitis with recombinant TCR ligands.Invest Ophthalmol Vis Sci2006https://conductscience.org/library/papers/16723470PubMed
1023576302Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.Eur J Immunol2013https://conductscience.org/library/papers/23576302PubMed
1120546940
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
J Neuroimmunol2010https://conductscience.org/library/papers/20546940PubMed
1232600443VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy.J Hematol Oncol2020https://conductscience.org/library/papers/32600443PubMed
1320870173The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism.Immunity2010https://conductscience.org/library/papers/20870173PubMed
1410591176Toxic MHC class II beta chains.Immunity1999https://conductscience.org/library/papers/10591176PubMed
1534249012Conversion of Anergic T Cells Into Foxp3- IL-10+ Regulatory T Cells by a Second Antigen Stimulus In Vivo.Front Immunol2021https://conductscience.org/library/papers/34249012PubMed
1628012172MHC class II alleles associated with Th1 rather than Th17 type immunity drive the onset of early arthritis in a rat model of rheumatoid arthritis.Eur J Immunol2017https://conductscience.org/library/papers/28012172PubMed
1715535832Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.Arthritis Res Ther2004https://conductscience.org/library/papers/15535832PubMed
1822124124Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory T cells.J Immunol2012https://conductscience.org/library/papers/22124124PubMed
191378019Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection.Eur J Immunol1992https://conductscience.org/library/papers/1378019PubMed
2016785524Lymphotoxin pathway-directed, autoimmune regulator-independent central tolerance to arthritogenic collagen.J Immunol2006https://conductscience.org/library/papers/16785524PubMed

See all 54 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
41451511Nanoparticle-Based Tolerogenic Vaccines: Next-Generation Strategies for Autoimmune and Allergic Disease Therapies.Angew Chem Int Ed Engl2026https://conductscience.org/library/papers/41451511PubMed
41012116Possible Anti-Pain Vaccines: A Narrative Review of Emerging Strategies and Clinical Prospects.Vaccines (Basel)2025https://conductscience.org/library/papers/41012116PubMed
40730179Vaccine therapy for rheumatoid arthritis: A step forward.Mol Ther2025https://conductscience.org/library/papers/40730179PubMed
40696875Self-Antigens Select B Cells: A New Perspective on B Cell Selection and Function.Eur J Immunol2025https://conductscience.org/library/papers/40696875PubMed
40285352Tolerogenic antigen-specific vaccine induces VISTA-enriched regulatory T cells and protects against arthritis in DRB1∗04:01 mice.Mol Ther2025https://conductscience.org/library/papers/40285352PubMed
39921498A Spleen-Targeted Tolerogenic mRNA-LNPs Vaccine for the Treatment of Experimental Asthma.Adv Sci (Weinh)2025https://conductscience.org/library/papers/39921498PubMed
39596089Targeted Therapy of Antibody-Induced Autoimmune Arthritis Using Peptide-Guided Nanoparticles.Int J Mol Sci2024https://conductscience.org/library/papers/39596089PubMed
39376556Overview of mechanisms and novel therapies on rheumatoid arthritis from a cellular perspective.Front Immunol2024https://conductscience.org/library/papers/39376556PubMed
39362875Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39362875PubMed
38903522Editorial: Exploring the role of T helper cells in autoimmune disease.Front Immunol2024https://conductscience.org/library/papers/38903522PubMed
38602454Human MHC Class II and Invariant Chain Knock-in Mice Mimic Rheumatoid Arthritis with Allele Restriction in Immune Response and Arthritis Association.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38602454PubMed

Download CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37307481

GET https://conductscience.org/api/papers/v1/37307481/references?page=2